Clinical Trials
5 trialsNCT06171685 2026-06-05
MMRC Horizon One: RRMM (MMRC-099)
Multiple Myeloma Research Consortium
Phase 2 Active not recruiting
NCT05243797 2026-06-04
MajesTEC-4
European Myeloma Network B.V.
Phase 3 Recruiting
NCT06918002 2026-06-01
ElLen
Intergroupe Francophone du Myelome
Phase 3 Recruiting
NCT04566328 2026-05-15
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Eastern Cooperative Oncology Group
Phase 3 Recruiting
NCT07085728 2026-05-15
Testing the Investigational Agent Combination of Daratumumab, Bortezomib, and Dexamethasone Compared to the Usual Treatment of Cyclophosphamide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients With Kidney Failure
Eastern Cooperative Oncology Group
Phase 2 Active not recruiting